Nowrouzian, Forough L. http://orcid.org/0000-0002-7454-1892
Stadler, Liselott Svensson
Östblom, Anna
Lindberg, Erika
Lina, Gerard
Adlerberth, Ingegerd
Wold, Agnes E.
Funding for this research was provided by:
Sahlgrenska Akademin (ALFGBG138401)
University of Gothenburg
Article History
Received: 22 July 2022
Accepted: 14 December 2022
First Online: 23 January 2023
Declarations
:
: The study was approved by the Ethics Committee of the University of Gothenburg, Sweden (R 448–97 and Ö 446–00).
: The informed consent was obtained from parents to all infants.
: The informed consent was obtained from parents to all infants.
: Agnes E. Wold, Ingegerd Adlerberth, and Bill Hesselmar hold shares in Flora Innovation AB, which is a research-driven company investigating potential preventative treatments for immune-mediated diseases. The other authors declare no conflict of interest.